The Molecular Pharmaceutics & Drug Delivery Seminar Series Presents:
Dr. Xiaoming Xu, Division Director at the FDA
Perception and Perspective: Fundamentals to Advance Complex Drug Product Development
Monday, April 8, 2024
4:00 p.m. – 5:00 p.m.
PHR 4.114
In-Person/Hybrid
Xiaoming Xu serves as a Division Director in the Office of Pharmaceutical Quality Research in FDA, where he leads multiple regulatory research areas such as complex formulations, nanomaterials and advanced manufacturing. In support of GDUFA III implementation, Xiaoming co-leads the complex PSG working group, with a focus of better integrating research in complex product-specific guidance (PSG) development.
He is also a member of FDA Nanotechnology Task Force and is responsible for developing international collaborative programs and standards in areas related to nanotechnology. Xiaoming is an editorial board member of the International Journal of Pharmaceutics. He received his B.S. and M.S. degrees in Pharmaceutics from China Pharmaceutical University and Ph.D. degree in Pharmaceutical Sciences from University of Connecticut.